DHA Pharmacist 2 — Questions and Answers
Question 1: A patient is prescribed simvastatin 40mg and is started on clarithromycin for a respiratory infection. What is the most significant drug interaction concern?
- Reduced clarithromycin efficacy
- Increased risk of myopathy/rhabdomyolysis due to elevated simvastatin levels (Correct answer)
- Reduced simvastatin cholesterol-lowering effect
- Clarithromycin-induced cardiac arrhythmia only
Correct answer: Increased risk of myopathy/rhabdomyolysis due to elevated simvastatin levels
Clarithromycin is a potent inhibitor of CYP3A4, which metabolizes simvastatin. Co-administration dramatically increases simvastatin plasma levels, increasing the risk of severe myopathy and rhabdomyolysis. Simvastatin should be temporarily suspended or switched to a non-CYP3A4-metabolized statin (e.g., pravastatin, rosuvastatin).
CYP3A4 inhibitors + simvastatin/lovastatin: avoid combination. Simvastatin is an HMG-CoA reductase inhibitor extensively metabolized by CYP3A4. CYP3A4 inhibitors (clarithromycin, itraconazole, HIV protease inhibitors, grapefruit juice) increase statin AUC 5–10×, greatly increasing myopathy risk. Rhabdomyolysis can cause acute kidney injury and death. DHA pharmacy regulations require screening for drug interactions at point of dispensing. Switch to pravastatin or rosuvastatin (CYP2C9 metabolized, minimal CYP3A4) during clarithromycin course.
Question 2: Under UAE Federal Law No. 14 of 1995 and DHA regulations, which category of medications requires a special permit for import and is subject to strict quantity limits on prescriptions?
- Antihypertensives
- Antibiotics
- Controlled substances (Schedule 1 narcotics/psychotropics such as morphine, tramadol, alprazolam) (Correct answer)
- Over-the-counter analgesics
Correct answer: Controlled substances (Schedule 1 narcotics/psychotropics such as morphine, tramadol, alprazolam)
UAE Federal Law No. 14/1995 on Narcotics and Psychotropic Substances strictly regulates Schedule 1 controlled substances including opioids (morphine, codeine, tramadol), benzodiazepines, and other psychotropics. Special prescriptions, quantity limits, and import permits are required. DHA pharmacists must comply with these requirements.
UAE controlled substance regulations: Federal Law No. 14/1995 as amended. Schedule 1 (most restricted): morphine, heroin, cocaine, certain benzodiazepines. Prescription requirements: special narcotic prescription pad, physician signature, patient ID, quantity in words and numbers, no repeats without new prescription. Tramadol is controlled in UAE — differs from many countries. Import by patients: require medical report + import permit from MOHAP for personal supply. Pharmacists: must verify prescription authenticity, maintain special records, report discrepancies to DHA. Violation = criminal penalty.
Question 3: A 70-year-old patient with atrial fibrillation is on warfarin. The pharmacist reviewing the medication list notices the patient was recently started on amiodarone. What action should the pharmacist take?
- No action needed as both are cardiac medications
- Recommend switching warfarin to aspirin immediately
- Alert the prescriber about the significant drug interaction — amiodarone inhibits warfarin metabolism, increasing bleeding risk, and INR monitoring must be intensified (Correct answer)
- Recommend increasing the warfarin dose immediately
Correct answer: Alert the prescriber about the significant drug interaction — amiodarone inhibits warfarin metabolism, increasing bleeding risk, and INR monitoring must be intensified
Amiodarone is a potent inhibitor of CYP2C9 (and other enzymes) which metabolizes warfarin. This interaction significantly increases warfarin levels and INR. The pharmacist should alert the prescriber, recommend more frequent INR monitoring, and anticipate a warfarin dose reduction of 30–50%.
Amiodarone-warfarin interaction: amiodarone inhibits CYP2C9 (S-warfarin metabolism) and CYP3A4 (R-warfarin). Effect: INR rises significantly (may double) within days to weeks. Management: alert prescriber, increase INR monitoring frequency (weekly initially), reduce warfarin dose by 30–50% empirically, counsel patient on bleeding signs. Amiodarone has a very long half-life (40–55 days) — interaction persists months after amiodarone discontinuation. This is a classic high-yield drug interaction on DHA pharmacy exams.
Question 4: What is the maximum number of days' supply for which a community pharmacist in Dubai can dispense a Schedule H (prescription-only) medication without a valid prescription for a known regular patient in an emergency?
- No emergency supply is permitted under any circumstances
- A 1-day supply (enough to continue until a prescription is obtained) (Correct answer)
- A 30-day supply to save the patient inconvenience
- A 7-day supply is always permitted
Correct answer: A 1-day supply (enough to continue until a prescription is obtained)
Emergency supply provisions in UAE/DHA allow pharmacists to dispense a limited quantity (typically 1 day or minimum necessary to bridge until a prescription is obtained) of a prescription medication in a genuine emergency where the patient cannot obtain a prescription and risk of harm from stopping is established. Controlled substances cannot be supplied this way.
DHA emergency supply guidelines: pharmacist may supply minimum quantity (typically 1 day's supply) of prescription medication when: genuine emergency, patient known to pharmacist on regular medication, prescriber cannot be reached, stopping medication poses direct risk. Must: record the supply, inform patient to obtain prescription immediately, not apply to controlled substances. This provision protects patient welfare while maintaining prescription requirements. Always document patient name, medication, quantity, date, and reason for emergency supply. Report to DHA if recurring emergency supplies are needed.
Question 5: A patient with renal impairment (eGFR 20 mL/min) is prescribed a medication. Which of the following drugs is LEAST likely to require dose adjustment in renal failure?
- Metformin
- Digoxin
- Atorvastatin (Correct answer)
- Gentamicin
Correct answer: Atorvastatin
Atorvastatin is primarily metabolized by the liver (CYP3A4) and excreted via bile with minimal renal elimination. No dose adjustment is required for renal impairment. Metformin, digoxin, and gentamicin are renally cleared and require dose reduction or avoidance in renal failure.
Renal dosing principles: drugs eliminated by kidney (renally cleared) require dose reduction in renal failure. Atorvastatin: hepatic metabolism + biliary excretion — no renal dose adjustment. Metformin: renally cleared, avoid if eGFR <30, risk of lactic acidosis. Digoxin: predominantly renal elimination, narrow therapeutic index — reduce dose and monitor levels in renal impairment. Gentamicin: renally excreted aminoglycoside — accumulates in renal failure causing nephrotoxicity and ototoxicity — requires dose adjustment and therapeutic drug monitoring. DHA pharmacists are expected to identify renally impaired patients and review dosing.
Question 6: The term 'bioequivalence' in pharmacy regulation refers to:
- Two drugs with the same chemical name but different manufacturers
- Two pharmaceutical products with the same active ingredient that achieve equivalent drug concentrations in blood (similar AUC and Cmax within acceptable limits, typically 80–125%) (Correct answer)
- Two drugs that have the same therapeutic effect regardless of blood levels
- Generic drugs that are manufactured in the same country as the originator
Correct answer: Two pharmaceutical products with the same active ingredient that achieve equivalent drug concentrations in blood (similar AUC and Cmax within acceptable limits, typically 80–125%)
Bioequivalence means two formulations of the same active ingredient produce statistically equivalent plasma drug concentrations (AUC and Cmax within 80–125% of each other). This is the regulatory basis for generic drug approval — bioequivalent generics can substitute for brand-name drugs.
Bioequivalence criteria (FDA/ICH/UAE MOHAP): AUC and Cmax of test vs. reference product within 80–125% confidence interval (90% CI). Established using crossover pharmacokinetic studies in healthy volunteers. Tmax (time to Cmax) is also reported. Bioequivalent drugs are considered therapeutically equivalent (same safety and efficacy). Exceptions: narrow therapeutic index drugs (warfarin, lithium, digoxin, phenytoin) require stricter bioequivalence criteria (90–111%). DHA and MOHAP regulate generic drug registration and require bioequivalence data for approval.
A patient is prescribed simvastatin 40mg and is started on clarithromycin for a respiratory infection.
What is the most significant drug interaction concern?